These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2395006

  • 1. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
    Iigo M, Nishikata K, Hoshi A.
    J Biol Response Mod; 1990 Aug; 9(4):426-30. PubMed ID: 2395006
    [Abstract] [Full Text] [Related]

  • 2. Effects of interleukin-2 and interferon-beta treatment on lymphocytes in various tumor-bearing mice.
    Iigo M, Nishikata K, Nakajima Y, Moriyama M.
    J Biol Regul Homeost Agents; 1989 Aug; 3(3):108-11. PubMed ID: 2516403
    [Abstract] [Full Text] [Related]

  • 3. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
    Iigo M, Sakurai M, Tamura T, Saijo N, Hoshi A.
    Cancer Res; 1988 Jan 15; 48(2):260-4. PubMed ID: 2446744
    [Abstract] [Full Text] [Related]

  • 4. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
    McIntosh JK, Mulé JJ, Krosnick JA, Rosenberg SA.
    Cancer Res; 1989 Mar 15; 49(6):1408-14. PubMed ID: 2784349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL, Stampfl S, Zimmerman RJ.
    Cancer Res; 1987 Aug 01; 47(15):3948-53. PubMed ID: 3496953
    [Abstract] [Full Text] [Related]

  • 12. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
    McIntosh JK, Mulé JJ, Merino MJ, Rosenberg SA.
    Cancer Res; 1988 Jul 15; 48(14):4011-7. PubMed ID: 3260130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H, Jansen R, MacPhee MJ, Keller J, McCormick K, Longo DL, Oppenheim JJ, Ruscetti FW, Wiltrout RH.
    J Immunol; 1990 Dec 15; 145(12):4121-30. PubMed ID: 2258610
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H, Tanaka N, Naomoto Y, Orita K.
    Jpn J Cancer Res; 1987 Nov 15; 78(11):1258-65. PubMed ID: 3121561
    [Abstract] [Full Text] [Related]

  • 17. In vivo effects of recombinant human interleukin 6, alone or in combination with local irradiation, on tumor growth in Lewis lung carcinoma-bearing mice.
    Lu L, Shen RN, Broxmeyer HE.
    Int J Cell Cloning; 1991 Sep 15; 9(5):511-20. PubMed ID: 1955739
    [Abstract] [Full Text] [Related]

  • 18. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS, Bowlin TL, Rosenberger AL, Fleischmann WR.
    J Biol Response Mod; 1989 Apr 15; 8(2):170-9. PubMed ID: 2499664
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S, Nakata K, Kashimoto S, Yoshida H, Yamada M.
    Jpn J Cancer Res; 1986 Aug 15; 77(8):767-73. PubMed ID: 3093425
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.
    Takeuchi T, Konno-Takahashi N, Kasuya Y, Ogushi T, Nishimatsu H, Kitamura T.
    BJU Int; 2004 Jul 15; 94(1):171-6. PubMed ID: 15217455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.